Opendata, web and dolomites

ImmunoCode SIGNED

Digital Single Cell Immunology: Decoding Cellular Interactions for Improved Immunotherapy

Total Cost €


EC-Contrib. €






 ImmunoCode project word cloud

Explore the words cloud of the ImmunoCode project. It provides you a very rough idea of what is the project "ImmunoCode" about.

longitudinally    successful    tremendous    transcriptomics    patients    cytotoxic    innovative    differently    induce    dendritic    cells    possess    strategies    immune    prime    heterogeneity    shows    extremely    despite    swiss    function    human    refining    tumour    environments    small    balance    subset    cellular    vaccines    technologies    pathogen    me    tight    immunity    massive    decoding    influence    specialized    augmented    remarkably    populations    superior    fact    interactions    heterogeneous    inducing    rare    pdc    population    functional    single    cancer    tolerance    opportunity    omission    regulate    knives    vaccine    functions    pdcs    pairs    amounts    vaccination    elusive    poorly    metastatic    ifns    risk    plasmacytoid    minimal    diseases    ultimately    infectious    anti    auto    immunology    multitude    secrete    effector    roles    revolutionise    act    unravel    exert    plasticity    erc    immunocode    ctls    battle    microfluidic    external    army    platform    exploited    cell    immunotherapy   

Project "ImmunoCode" data sheet

The following table provides information about the project.


Organization address
address: GROENE LOPER 3
postcode: 5612 AE

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Total cost 1˙812˙143 €
 EC max contribution 1˙812˙143 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2018-STG
 Funding Scheme ERC-STG
 Starting year 2018
 Duration (year-month-day) from 2018-11-01   to  2023-10-31


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 


 Project objective

Successful immunotherapy against cancer is the result of a multitude of cellular interactions within the immune system. It is highly exciting how vaccination with small numbers of human plasmacytoid dendritic cells (pDCs) can induce anti-tumour immunity in metastatic cancer patients. Remarkably, how pDCs, as an extremely rare subset of cells, can act as Swiss army knives to regulate the tight balance between tolerance and immunity: i.e. secrete massive amounts of type I IFNs, prime T cells and exert cytotoxic effector functions, is still elusive. Do pDCs possess all functions or comprises the population distinct functional subsets all with their specialized roles. I will unravel which pDC is superior in inducing cytotoxic T cells (CTLs) for augmented cancer immunity. Despite advances in single cell technologies, understanding the role of heterogeneity in immune cell populations, remains poorly understood. In ImmunoCode, I will develop a novel and ambitious single cell technology platform, wherein innovative microfluidic approaches and single cell transcriptomics allow 1) functional analysis of single (pairs of) immune cells and 2) design of minimal environments under the omission of external factors that could influence cellular behaviour. This approach will provide me with the unique opportunity to unravel pDC function and plasticity. Although in this ERC proposal I will focus on understanding pDCs heterogeneity, my technology can in fact be exploited to any cell type that shows heterogeneous function. My unique and high-risk technical approach allows for decoding immune cell-cell or cell-pathogen interactions longitudinally and in great detail which will revolutionise the fields of immunology and cellular immunotherapy. Ultimately, ImmunoCode will have a tremendous impact by refining the design of vaccine strategies and the development of differently composed cellular vaccines to battle cancer and infectious and auto-immune diseases.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "IMMUNOCODE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "IMMUNOCODE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

NanoPD_P (2020)

High throughput multiplexed trace-analyte screening for diagnostics applications

Read More  

FuncMAB (2019)

High-throughput single-cell phenotypic analysis of functional antibody repertoires

Read More  


Precision medicine in traumatic brain injury using individual neurosteroid response

Read More